Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02263716 · ClinicalTrials.gov registry record
Actigraphy to MEasuRe Intensive Care Unit Activity
A clinical trial, sponsored by Vanderbilt University.
- Completed
- Registry status
- 25
- Enrollment target
NCT02263716: Completed study, sponsored by Vanderbilt University.
NCT02263716 is a clinical trial that has completed, run by Vanderbilt University. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02263716 has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
This study is to determine whether accelerometry can be used to measure physical activity occurring during routine clinical care in a diverse population of patients with medical or surgical critical illness.
Primary Outcome
To determine the validity of activity counts from each of the three accelerometry sites (wrist, hip and ankle) with direct observation acting as the reference.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2015-07 |
| Est. Completion | 2016-02 |
What the finished NCT02263716 record still lists
NCT02263716 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02263716 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02263716 about?
NCT02263716 is a clinical study titled "Actigraphy to MEasuRe Intensive Care Unit Activity". This study is to determine whether accelerometry can be used to measure physical activity occurring during routine clinical care in a diverse population of patients with medical or surgical critical illness.
What is the current status of trial NCT02263716?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2015-07. Estimated completion is 2016-02.
Who is sponsoring clinical trial NCT02263716?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia